Picture

Exon 20 Group, a multi-stakeholder organization @Exon20Group

Global org: patients/carers, HCPs, pharma, labs, scientists, working to cure #NSCLC #HER2 & #EGFR #Exon20 insertions (in 25 cancers +) [email protected] exon20group.org 72 countries served Joined July 2017
  • Tweets
    985
  • Followers
    2K
  • Following
    4K
  • Likes
    1K
Exon20Group Profile Picture

Exon 20 Group, a multi-stakeholder organization @Exon20Group

a day ago

On #WorldIPDay, we salute the brilliant clinicians & scientists & all those involved in the drug discovery pipeline. These heroes work tirelessly to create & develop innovative drugs & treatments that extend & save lives--all made possible by strong intellectual property…

Exon 20 Group, a multi-stakeholder organization retweeted
DRCamidge Profile Picture

D. Ross Camidge @DRCamidge

2 weeks ago

12 years ago we coined the term ‘oligoprogression’ describing ‘weeding the garden’ with SBRT/SRS for this scenario on targeted therapy in lung cancer. Although there were initial haters, they came round. This is our new update, but it’s way beyond CU now. advancesradonc.org/article/S2452-…

Exon20Group Profile Picture

Exon 20 Group, a multi-stakeholder organization @Exon20Group

2 weeks ago

Important open-access article for patients with actionable mutations/fusions #NSCLC--Bravo to @CUAnschutz @DRCamidge @TejasPatilMD and #radonc colleagues at #UCDenver advancesradonc.org/article/S2452-…

Exon 20 Group, a multi-stakeholder organization retweeted
DanaFarberNews Profile Picture

Dana-Farber News @DanaFarberNews

3 weeks ago

#LungCancer data at #AACR24: @DanaFarber's Pasi Jänne, MD, PhD, reports on ctDNA with an EGFR mutation in FLAURA2 trial. The new data shows patients whose blood tested positive before therapy for tumor cell DNA with EGFR mutations stood to gain the most from combination therapy.

Exon 20 Group, a multi-stakeholder organization retweeted
BijoyTelivala Profile Picture

Bijoy Telivala @BijoyTelivala

a month ago

@esinghimd @StephenVLiu @EGFRResisters @Exon20Group @jillfeldman4 @ADesaiMD @LungCancerRx @PatelOncology @NarjustFlorezMD @Latinamd So true But it’s tough to get derm consults in community You end up being the Oncologist + Dermatologist ( like we do for Cetux )

Exon 20 Group, a multi-stakeholder organization retweeted
SuyogCancer Profile Picture

Dr Amol Akhade @SuyogCancer

3 weeks ago

How to treat advanced NSCLC without driver mutations. First and second line . All IO drugs combinations . Nice tables for quick reference in clinical practice. Check contraindications for bevacizumab. @ASCO @JCO_ASCO

Exon 20 Group, a multi-stakeholder organization retweeted
chulkimMD Profile Picture

Chul Kim @chulkimMD

3 weeks ago

Just out @CACancerJournal 'Global cancer statistics 2022: #GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries' Global maps showing the most common type of cancer mortality among men and women 👇 Lung cancer shown in Blue @AmericanCancer

Exon 20 Group, a multi-stakeholder organization retweeted
BiagioRicciutMD Profile Picture

Biagio Ricciuti, MD PhD @BiagioRicciutMD

4 weeks ago

🚨Our collaborative effort to characterize #MET kinase domain mutations as novel & targetable alterations in #NSCLC and other cancer types is out in @CD_AACR! Led by💫scientists @pecci_federica1 & Seshiru Nakazawa @DanaFarberNews @OncoAlert #LCSM shorturl.at/huRT2 1/4🧵

Exon 20 Group, a multi-stakeholder organization retweeted
ValsamoA Profile Picture

Elsa Anagnostou @ValsamoA

3 weeks ago

Published in @CD_AACR ahead of #AACR24 our vision for pushing the boundaries of #liquidbiopsies through transformative technologies and clinical implementation for early precision intervention. @velculescu @HopkinsThoracic @AACR doi.org/10.1158/2159-8…

Exon 20 Group, a multi-stakeholder organization retweeted
esinghimd Profile Picture

Eric K. Singhi, MD @esinghimd

3 weeks ago

Proud to work with @LUNGevity & team to develop a discussion guide for biomarker testing for patients with solid tumors. Learn more here: lungevity.org/biomarkerdiscu… #patienteducation #lcsm

Exon 20 Group, a multi-stakeholder organization retweeted
StephenVLiu Profile Picture

Stephen V Liu, MD @StephenVLiu

a month ago

Join us virtually April 11-12 for this @MedscapeLIVE NSCLC conference! Comprehensive updates & live Q&A led by co-chairs Drs. @CharuAggarwalMD Tina Cascone @IbiayiMD @benlevylungdoc @ZPiotrowskaMD and dynamic engaging speakers! #PLCClive24 Register at ms.spr.ly/6012c3H8A

Exon 20 Group, a multi-stakeholder organization retweeted
VivekSubbiah Profile Picture

Vivek Subbiah, MD @VivekSubbiah

3 weeks ago

💥Just published in light of @AACR Annual Meeting #AACR24 🥁Our paper unveils a transformative "Vision for democratizing Next-Generation Oncology Clinical Trials" 🙌Let's unite researchers, clinicians, patients & policymakers to make trials more inclusive & accessible. Together,…

Exon20Group Profile Picture

Exon 20 Group, a multi-stakeholder organization @Exon20Group

3 weeks ago

Great news for #HER2 patients across the country. Now let’s please have regulatory agencies beyond the U.S. quickly follow the @FDAOncology lead. #LCSM

Dr_R_Kurzrock Profile Picture

Razelle Kurzrock, MD @Dr_R_Kurzrock

3 weeks ago

Great news for #HER2 patients across the country. Now let’s please have regulatory agencies beyond the U.S. quickly follow the @FDAOncology lead. #LCSM

Exon 20 Group, a multi-stakeholder organization retweeted
OliverIllini Profile Picture

Oliver Illini @OliverIllini

4 weeks ago

New @MDPIOpenAccess 🌔MOON: International RWD 🌎 on #mobocertinib in #EGFR Exon20 #lungcancer ✅efficacy pre/post #amivantamab 🔬postprogression analysis 🚺7x more likely to stop due to AE doi.org/10.3390/ijms25… @Exon20Group @OncoAlert @EGFRResisters @EGFRmNSCLC

Exon 20 Group, a multi-stakeholder organization retweeted
MDuruisseaux Profile Picture

Michael Duruisseaux @MDuruisseaux

3 weeks ago

🚨Hot of the press @MDPIOpenAccess RWD registry about mobocertinib activity in Ex20EGFR-mutated NSCLC 🧠 activity, mechanism of resistance, AEs very happy to participate to this excellent work led by @OliverIllini @Exon20Group #LCMC x.com/OliverIllini/s…

OliverIllini Profile Picture

Oliver Illini @OliverIllini

4 weeks ago

🚨Hot of the press @MDPIOpenAccess RWD registry about mobocertinib activity in Ex20EGFR-mutated NSCLC 🧠 activity, mechanism of resistance, AEs very happy to participate to this excellent work led by @OliverIllini @Exon20Group #LCMC x.com/OliverIllini/s…

Exon 20 Group, a multi-stakeholder organization retweeted
jsoriamd Profile Picture

soria @jsoriamd

4 weeks ago

Lung cancer in never-smokers represent the 5thleading cause of cancer-related mortality in the world. They are highly enriched for targetable oncogenic alterations, have low TMB, low rates of PD-L1 positivity, & lack mutational signatures. They occur almost exclusively as…

Exon 20 Group, a multi-stakeholder organization retweeted
LeXiuning Profile Picture

Xiuning Le MD PhD @LeXiuning

4 weeks ago

#ASCO Educational Book with @stephanieplsaw @JordiRemon @HendriksLizza Look forward to this year's ASCO educational sessions. @EGFRResisters @Exon20Group @MDAndersonNews

JordiRemon Profile Picture

Jordi Remon @JordiRemon

4 weeks ago

#ASCO Educational Book with @stephanieplsaw @JordiRemon @HendriksLizza Look forward to this year's ASCO educational sessions. @EGFRResisters @Exon20Group @MDAndersonNews

Exon 20 Group, a multi-stakeholder organization retweeted
KatsuakiMaehara Profile Picture

Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara

4 weeks ago

Cont. 3 / 4 📌 Ras pathway 📌 📌 Others 📌 🔈 End….🙇

Exon 20 Group, a multi-stakeholder organization retweeted
KatsuakiMaehara Profile Picture

Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara

4 weeks ago

Cont. 3 / 4 📌 fusions 📌 📌 Ras pathway 📌

Exon 20 Group, a multi-stakeholder organization retweeted
KatsuakiMaehara Profile Picture

Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara

4 weeks ago

Cont. 2 / 4 📌 EGFR 📌 📌 HER2 / HER3 / TROP2 📌 📌 MET 📌

Trends for United States

#TexasHockey
5.380 posts
WYATT JOHNSTON
2.994 posts
Logan Thompson
2.046 posts
#bucciovertimechallenge
3.812 posts
Mike Perry
2.986 posts
Colin Jost
23,3 B posts
#VegasBorn
3.096 posts
Lakers in 7
22,9 B posts
Oklahoma
62,9 B posts
#GagCityMinneapolis
18,4 B posts
No. Twitter
1,15 Mn posts
#Wordle1044
Sick New World
5.041 posts
FaZe
38,8 B posts
Chivas
37,2 B posts
Marner
13,7 B posts
Darby
4.190 posts
Leafs
34,2 B posts
Cornette
1.854 posts
Spellify 48

You might like

A group of EGFR+ lung cancer patients who are resistant to targeted treatment. Sharing support & research news, accelerating research, improving outcomes. #lcsm
EGFR Resisters
@EGFRResisters
5K Followers
I am Executive Director at the Center for Thoracic Oncology at Mount Sinai Hospital , NYC and Professor of Medicine at Icahn Medical School at Mount Sinai, NY
Fred R. Hirsch
@fred_hirsch
3K Followers
Roy Herbst
@DrRoyHerbstYale
6K Followers
Chief of Thoracic Medical Oncology and Director of Lung Cancer Risk Assessment at Fox Chase Cancer Center
Hossein Borghaei, DO
@HosseinBorghaei
5K Followers
The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
IASLC
@IASLC
19K Followers
Global community of patients & caregivers improving outcomes for ROS1+ cancers through community, education and research. #ROS1cancer #LCSM
The ROS1ders, Inc.
@ros1cancer
2K Followers
We are a patient-driven organization, dedicated to improving the life expectancy & quality of life for ALK-positive cancer patients worldwide. #StrongerTogether
ALK Positive
@ALKPositiveinc
2K Followers
Summit: Nov 2-4, 2023 • Chicago, IL • @egfrresisters @CEC_onc Abstract Submission Deadline: CLOSED⏩https://t.co/i1jrgLUVG3
EGFR Resisters Resear..
@EGFRSummit
1K Followers
Lung Cancer Patient and Advocate, Co-Founder @EGFRResisters, wife, mom of 4, #LCSM #lungcancer #HealthEquity #EndStigma #RockChalk
Jill Feldman
@jillfeldman4
8K Followers
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl
Charu Aggarwal, MD, M..
@CharuAggarwalMD
11K Followers
Program Director, Cancer Early Detection & Diagnostics @MGHCancerCenter #Equity @mgh_fhs #NoOneDeservesLungCancer #ScreeningSavesLives @IASLC She/her
Lecia Sequist, MD, MP..
@LeciaSequist
10K Followers
MD PhD | Medical Oncologist | Clinical Research Medical Director @Amgen | Views expressed are my own
Gonzalo Recondo
@GRecondoMD
2K Followers
Thoracic/precision oncology 🇭🇺🇺🇸 Country music singer- The White Lungs
Balazs Halmos
@DrSteveMartin
8K Followers
Associate Professor Thoracic Head and Neck Medical Oncology MD Anderson Cancer Center
Xiuning Le MD PhD
@LeXiuning
1K Followers
lung cancer oncologist & researcher @IEOufficiale
Aɴᴛᴏɴɪᴏ Pᴀ..
@APassaroMD
6K Followers